BANK VONTOBEL AG | Market Closed - Bid/Ask 11:20:00 2024-06-21 am EDT | After market 11:15:01 am | |||
| 100.5 USD | -0.10% |
|
100.4 | -0.15% |
| 3 months | -0.40% | ||
| 6 months | +2.24% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|
Delayed Quote Swiss Exchange
Last update June 21, 2024 at 11:20 am EDT
More quotesStatic data
| Product type | Reverse Convertibles |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
Vontobel
|
| RLLABV | |
| ISIN | CH1283323124 |
| Date issued | 2023-09-08 |
| Strike | 586.5 $ |
| Maturity | 2024-09-09 (74 Days) |
| Parity | 0.59 : 1 |
| Emission price | 100 $ |
| Emission volume | N/A |
| Settlement | both |
| Currency | USD |
Technical Indicators
| Highest since issue | 101 $ |
|---|---|
| Lowest since issue | 95.8 $ |
| Spread | 5 $ |
| Spread % | 0.50% |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
901.3
USD
Average target price
860.5
USD
Spread / Average Target
-4.52%
- Stock Market
- Certificates
- RLLABV Certificat
